Task force on sudden cardiac death of the European Society of Cardiology

SG Priori, E Aliot, C Blomstrom-Lundqvist… - European heart …, 2001 - academic.oup.com
The members of the Task Force on Sudden Death dedicate this paper to the memory of our
former friend and colleague, Professor Ronald WF Campbell. Ronnie spent his life working …

Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy

P Søgaard, H Egeblad, WY Kim, HK Jensen… - Journal of the American …, 2002 - jacc.org
Objectives: We sought to evaluate the long-term impact of cardiac resynchronization therapy
(CRT) on left ventricular (LV) performance and remodeling using three-dimensional …

Dose-related kinetics of aspirin: presystemic acetylation of platelet cyclooxygenase

AK Pedersen, GA FitzGerald - New England Journal of Medicine, 1984 - Mass Medical Soc
When aspirin is administered by mouth in low doses, poor systemic bioavailability may
contribute to its apparent dose-related" selective inhibition" of THROMBOXANE A2 …

A randomized comparison ofatrial and dual-chamber pacing in177 consecutive patients with sick sinus syndrome: Echocardiographic and clinical outcome

JC Nielsen, L Kristensen, HR Andersen… - Journal of the American …, 2003 - jacc.org
Objectives: A randomized trial was done to compare single-chamber atrial (AAI) and dual-
chamber (DDD) pacing in patients with sick sinus syndrome (SSS). Primary end points were …

Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome

HR Andersen, JC Nielsen, PEB Thomsen, L Thuesen… - The Lancet, 1997 - thelancet.com
Background In a previous study of 225 patients with sicksinus syndrome randomised to
either single-chamber atrial pacing (n= 110) or single-chamber ventricular pacing (n= 115) …

Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation

GA FitzGerald, B Smith, AK Pedersen… - New England Journal …, 1984 - Mass Medical Soc
Prostacyclin is a potent vasodilator and platelet inhibitor produced by vascular endothelium.
Endogenous production of prostacyclin under physiologic conditions is extremely low, far …

Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging

P Sogaard, H Egeblad, AK Pedersen, WY Kim… - Circulation, 2002 - Am Heart Assoc
Background—Cardiac resynchronization therapy (CRT) by means of simultaneous
biventricular pacing improves left ventricular systolic performance and synchrony in patients …

[HTML][HTML] α-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy

J Mogensen, IC Klausen, AK Pedersen… - The Journal of …, 1999 - Am Soc Clin Investig
We identified the α-cardiac actin gene (ACTC) as a novel disease gene in a pedigree
suffering from familial hypertrophic cardiomyopathy (FHC). Linkage analyses excluded all …

Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.

GA FitzGerald, AK Pedersen, C Patrono - Circulation, 1983 - Am Heart Assoc
THE APPRECIATION that two oxygenated metabolites of arachidonic acid, prostacyclin
(PGI2) and thromboxane A2 (TxA2), have potent and contrasting effects on vascular tone …

UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites

V Akimov, I Barrio-Hernandez, SVF Hansen… - Nature structural & …, 2018 - nature.com
Ubiquitination is a post-translational modification (PTM) that is essential for balancing
numerous physiological processes. To enable delineation of protein ubiquitination at a site …